ライフサイエンスコーパス: simian

1 erologous prime-boost with the viral vectors simian adenovirus 63 (ChAd63)-modified vaccinia virus An

2 prototypical betaretrovirus responsible for simian AIDS (SAIDS) in rhesus macaques.

3 l swarm and allowed to naturally progress to simian AIDS and potential SIV-associated encephalitis (S

4 Because these animals do not develop simian AIDS despite maintaining high viral loads, there

5 As they do not develop simian AIDS, there is great interest in understanding ho

6 mentalization was diminished in animals with simian AIDS, which often have low-frequency CTL response

7 y associated with lymphomas in macaques with simian AIDS.

8 re a natural host of SIV that do not develop simian AIDS.

9 r ribosomes and associated mRNAs from human, simian and mice cellular extracts, but did not selective

10 d complex manual behaviors in most Old World simians and in the New World cebus monkey.

11 gVagm; in 7% of animals), and numerous novel simian anelloviruses (in 100% of animals).

12 ured mammalian cells, worms, flies, rodents, simians, apes, and even humans, all indicate declining a

13 iviruses (family Flaviviridae) and two novel simian arteriviruses (family Arteriviridae) in wild Afri

14 patterns of evolution differ markedly among simian arteriviruses and among host species.

15 the phylogenetic and geographic range of the simian arteriviruses and define baboons as a natural hos

16 Simian arteriviruses are a diverse clade of viruses infe

17 Simian arteriviruses are a diverse group of related viru

18 t in addition to SIV, simian pegiviruses and simian arteriviruses are widespread and prevalent among

19 Our results indicate that multiple divergent simian arteriviruses can cause SHF.

20 en together, these features suggest that the simian arteriviruses may be "preemergent" zoonotic patho

21 the genetic and geographic diversity of the simian arteriviruses, identify baboons as a natural host

22 suggests that one of these virus types, the simian arteriviruses, may have the potential to jump bet

23 at have been rendered selective for human or simian CD4(+) cells by surface engineering.

24 t hepatocyte cultures through the use of the simian CD81 ortholog as a coreceptor, indicating that HC

25 e was no restriction in HCV entry into these simian cells.

26 nsory nerve fibers and initially entered the simian CNS at lumbar spinal cord levels.

27 foodborne BSE-associated prions entered the simian CNS via afferent neurons.

28 the interspecies transmission of STLV-1 (its simian counterpart) remain largely unknown.

29 Together with their simian counterparts, HTLVs form the primate T-lymphotrop

30 ng vaccination with human-, chimpanzee-, and simian-derived rAds encoding SIV-Gag antigen (Ag).

31 specimens were not reliable for detection of simian disease carriers before onset of clinical signs.

32 egion from all currently recognized human or simian EV species.

33 in global redistribution of PFV and macaque simian foamy virus (SFVmac) integration sites toward cen

34 Thirteen (56%) were coinfected with a simian foamy virus known to be acquired through severe b

35 Zoonotic transmission of Old World NHP simian foamy viruses (SFV) has been documented, leading

36 Simian foamy viruses (SVF) are ubiquitous in nonhuman pr

37 Simian hemorrhagic fever (SHF) is lethal for macaques.

38 have played a role in previous outbreaks of simian hemorrhagic fever in macaques, as has long been s

39 Simian hemorrhagic fever virus (SHFV) causes a fatal hem

40 Simian hemorrhagic fever virus (SHFV) causes a severe an

41 Simian hemorrhagic fever virus (SHFV) causes highly leth

42 entally infected crab-eating macaques, while simian hemorrhagic fever virus (SHFV) causes lethal vira

43 The N-terminal region of simian hemorrhagic fever virus (SHFV) nonstructural poly

44 es and then crab-eating macaques with either simian hemorrhagic fever virus (SHFV) or Kibale red colo

45 were previously reported for the arterivirus Simian hemorrhagic fever virus (SHFV).

46 used by different strains of the same virus, simian hemorrhagic fever virus (SHFV; Arteriviridae).

47 Close relatives of these viruses, including simian hemorrhagic fever virus, have caused sporadic out

48 t HCV sequences designed to allow entry into simian hepatocytes failed to induce viremia in tamarins

49 cessfully complete its life cycle in primary simian hepatocytes, suggesting the possibility of adapti

50 nv proteins of simian immunodeficiency virus/simian HIV (SIV/SHIV) stock and T/F variants in search o

51 red with those infected with less pathogenic simian HIV, vaccinated and SIVmac-challenged, or SIVmac-

52 hen administered by injection that prevented simian-HIV infection upon repeat intrarectal challenge i

53 cutive low-dose intravaginal challenges with simian-HIV strain SF162P3, with more animals infected co

54 (and may have increased susceptibility to a simian-HIV vaginal challenge), while the microbicide red

55 ct of stem cell transplantation in a macaque simian/HIV (SHIV) system.

56 a primary HIV-1 isolate (HIV-1JR-FL), and a simian-human immunodeficiency virus (SHIV) adapted for p

57 opment of a panel of mucosally transmissible simian-human immunodeficiency virus (SHIV) challenge sto

58 pentavalent-vaccine-immunized macaques from simian-human immunodeficiency virus (SHIV) challenge.

59 s (bNAbs) can protect rhesus monkeys against simian-human immunodeficiency virus (SHIV) challenge.

60 a proportion of CD4(+) T cells resistant to simian-human immunodeficiency virus (SHIV) entry were ch

61 Vh-LS-F potently inhibited in vivo HIV-1 and simian-human immunodeficiency virus (SHIV) infection in

62 ain) elicits heterologous protection against simian-human immunodeficiency virus (SHIV) or simian imm

63 broadly neutralizing MAbs to suppress acute simian-human immunodeficiency virus (SHIV) replication i

64 as they incompletely neutralize the clade C simian-human immunodeficiency virus (SHIV) stock (SHIV-3

65 ith pig-tailed macaques demonstrated various simian-human immunodeficiency virus (SHIV) susceptibilit

66 imary isolates in vitro and protects against simian-human immunodeficiency virus (SHIV) when delivere

67 h reduced infection rates in studies of HIV, simian-human immunodeficiency virus (SHIV), and simian i

68 m 16 simian immunodeficiency virus (SIV)- or simian-human immunodeficiency virus (SHIV)-infected and

69 ion, simian immunodeficiency virus (SIV)- or simian-human immunodeficiency virus (SHIV)-infected nonh

70 between neutralizing antibodies elicited by simian-human immunodeficiency virus (SHIV)-infected rhes

71 ed V3-glycan antibody PGT121, in chronically simian-human immunodeficiency virus (SHIV)-SF162P3-infec

72 ave shown that simian immunodeficiency virus/simian-human immunodeficiency virus (SIV/SHIV) exposure

73 5-tropic strains SIVmac239, SIVsmE543-3, and simian-human immunodeficiency virus SHIV-AD8 in RM PBMC.

74 matical models in conjunction with data from simian-human immunodeficiency virus SHIV89.6P infection

75 sus macaques were inoculated orally with the simian-human immunodeficiency virus SHIVSF162P3.

76 d raises a cautionary note for SIV and SHIV (simian-human immunodeficiency virus) vaccine studies tha

77 of the ICs targeted with 7B2 in mice and in simian-human immunodeficiency virus-infected macaques.

78 Here, we infected rhesus macaques with simian-human immunodeficiency viruses (SHIV) and followe

79 cell loss in vivo, we infected macaques with simian-human immunodeficiency viruses (SHIV) and followe

80 Most simian-human immunodeficiency viruses (SHIVs) bearing en

81 erred complete immunity against a mixture of simian-human immunodeficiency viruses (SHIVs) in nonhuma

82 coded" challenge viruses and next-generation simian-human immunodeficiency viruses that may advance t

83 nst a single high-dose challenge with HIV or simian/human (SIV/HIV) chimaeric viruses (SHIVs) respect

84 of TAF and emtricitabine (FTC) could prevent simian/human immunodeficiency virus (SHIV) infection in

85 t early administration of bNAbs in a macaque simian/human immunodeficiency virus (SHIV) model is asso

86 Macaques were exposed to simian/human immunodeficiency virus (SHIV) vaginally eac

87 nterruption data from macaques infected with simian/human immunodeficiency virus (SHIV), we observe a

88 (8-15 y) and old (>20 y) RM with recombinant simian IL-7 (rsIL-7) results in only transient increases

89 of human immunodeficiency type 1 (HIV-1) and simian immunodeficiency (SIV) infections.

90 s that were molecularly engineered with anti-simian immunodeficiency virus (anti-SIV) activity into r

91 Chronic human immunodeficiency virus and simian immunodeficiency virus (HIV and SIV) infections a

92 The cytoplasmic tails of human and simian immunodeficiency virus (HIV and SIV, respectively

93 d rhesus macaques infected with the human or simian immunodeficiency virus (HIV or SIV), respectively

94 thway in human immunodeficiency virus type 1/simian immunodeficiency virus (HIV-1/SIV) infection rema

95 or site of inflammation during chronic human/simian immunodeficiency virus (HIV/SIV) infection.

96 ence of a distinct subpopulation of human or simian immunodeficiency virus (HIV/SIV) sequences within

97 However, with the exception of simian immunodeficiency virus (SIV) (family Retroviridae

98 imian-human immunodeficiency virus (SHIV) or simian immunodeficiency virus (SIV) acquisition in three

99 ine-induced antibodies to capture infectious simian immunodeficiency virus (SIV) and explored the rel

100 We found here that an ALVAC-simian immunodeficiency virus (SIV) and gp120 alum (ALVA

101 nodes from pigtailed macaques infected with simian immunodeficiency virus (SIV) carrying HIV-1 rever

102 e that showed significant protection against simian immunodeficiency virus (SIV) challenge and sugges

103 e route on protection against a heterologous simian immunodeficiency virus (SIV) challenge.

104 cytes (CD8TL) are associated with control of simian immunodeficiency virus (SIV) despite extensive ne

105 se macaques consistently displayed low-level simian immunodeficiency virus (SIV) diversity, which was

106 ls (DCs) and B cells, as an adjuvant for our simian immunodeficiency virus (SIV) DNA vaccine in rhesu

107 mmunization, or the capacity to neutralize a simian immunodeficiency virus (SIV) Env-expressing pseud

108 human immunodeficiency virus type 1 (HIV-1)/simian immunodeficiency virus (SIV) envelope spike (Env)

109 ural-host sooty mangabeys (SM) infected with simian immunodeficiency virus (SIV) exhibit high viral l

110 nt study, we found that protection following simian immunodeficiency virus (SIV) exposure correlated

111 TANCE Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) express a small prot

112 lymorphism limits and complicates the use of simian immunodeficiency virus (SIV) for evaluation of hu

113 We deep sequenced simian immunodeficiency virus (SIV) from Mauritian cynom

114 ycobacterium tuberculosis strains expressing simian immunodeficiency virus (SIV) genes safely induces

115 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) gp120 exterior envel

116 ons.IMPORTANCE Rhesus macaque infection with simian immunodeficiency virus (SIV) has served as an imp

117 ts of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) have been described

118 African-origin, natural simian immunodeficiency virus (SIV) hosts do not typical

119 -1)-infected humans, African-origin, natural simian immunodeficiency virus (SIV) hosts, such as Afric

120 n immunodeficiency virus (HIV) in humans and simian immunodeficiency virus (SIV) in macaques (MAC) le

121 on of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) in vivo is well esta

122 GI) tract of Asian macaques with progressive simian immunodeficiency virus (SIV) infection and humans

123 erable to human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection and thus a

124 HIV/simian immunodeficiency virus (SIV) infection causes bre

125 The time to acquisition of simian immunodeficiency virus (SIV) infection following

126 ght contribute to the asymptomatic nature of simian immunodeficiency virus (SIV) infection in its nat

127 re changes in mucosal IL-10 signaling during simian immunodeficiency virus (SIV) infection in rhesus

128 n genes that show a response to experimental simian immunodeficiency virus (SIV) infection in vervet

129 AIDS caused by simian immunodeficiency virus (SIV) infection is associa

130 re we studied progressive and nonprogressive simian immunodeficiency virus (SIV) infection models in

131 age proliferation occurs in the brain during simian immunodeficiency virus (SIV) infection of adult m

132 Studies of natural, nonpathogenic simian immunodeficiency virus (SIV) infection of African

133 During acute simian immunodeficiency virus (SIV) infection, gut homin

134 n pathways involved in establishing systemic simian immunodeficiency virus (SIV) infection, we necrop

135 on during human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection.

136 ospinal fluid of rhesus monkeys with chronic simian immunodeficiency virus (SIV) infection.

137 isposed to more pathogenic manifestations of simian immunodeficiency virus (SIV) infection.

138 mation and gut immune dysfunction during the simian immunodeficiency virus (SIV) infection.

139 Currently available simian immunodeficiency virus (SIV) infectious molecular

140 A subtype C isolate was similar, while a simian immunodeficiency virus (SIV) isolate showed signi

141 different human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) lentiviruses.

142 tissue (GALT) and have a key role in HIV and simian immunodeficiency virus (SIV) pathogenesis.

143 ) lymphocyte-depleted macaques infected with simian immunodeficiency virus (SIV) provide an increasin

144 is of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) reflects a balance b

145 Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication in human

146 Chronic-phase HIV and simian immunodeficiency virus (SIV) replication is reduc

147 ions, human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication may cont

148 We developed a method to capture total-body simian immunodeficiency virus (SIV) replication using im

149 also predisposes rhesus macaques to control simian immunodeficiency virus (SIV) replication.

150 d in all primate lentiviruses, and its HIV-2/simian immunodeficiency virus (SIV) SIVsm paralogue Vpx,

151 Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) strains differ in th

152 The lentiviruses HIV and simian immunodeficiency virus (SIV) subvert intracellula

153 HIV and simian immunodeficiency virus (SIV) target CD4(+) T cell

154 abeys (SM) are well-studied natural hosts of simian immunodeficiency virus (SIV) that do not progress

155 g in rhesus macaques (Macaca mulatta) during simian immunodeficiency virus (SIV) transmission and acu

156 ted DNA/modified vaccinia virus Ankara (MVA) simian immunodeficiency virus (SIV) vaccine enhances pro

157 alization sieve effect in a nonhuman primate simian immunodeficiency virus (SIV) vaccine trial (DNA p

158 Working with the macaque simian immunodeficiency virus (SIV) vaginal challenge mo

159 o evaluate antibody specificities induced by simian immunodeficiency virus (SIV) versus human immunod

160 ned the G2/M arrest phenotypes of a panel of simian immunodeficiency virus (SIV) Vpr proteins.

161 20 of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) was investigated for

162 (HIV) emergence following human exposures to simian immunodeficiency virus (SIV), an understanding of

163 sory proteins of primate lentiviruses HIV-1, simian immunodeficiency virus (SIV), and BIV all form ub

164 can green monkeys (AGM) are natural hosts of simian immunodeficiency virus (SIV), and infection in th

165 quely valuable for genetic investigations of simian immunodeficiency virus (SIV), for which it is the

166 sum A1 partially inhibited HIV-1, as well as simian immunodeficiency virus (SIV), murine leukemia vir

167 nhuman primates were coinfected with Mtb and simian immunodeficiency virus (SIV), recapitulating huma

168 Studies of natural HIV-1 infection, simian immunodeficiency virus (SIV)- or simian-human imm

169 orescence microscopy thoracic aortas from 16 simian immunodeficiency virus (SIV)- or simian-human imm

170 To this end, preclinical simian immunodeficiency virus (SIV)-based nonhuman prima

171 ere validated in archival brain tissues from Simian Immunodeficiency Virus (SIV)-infected and uninfec

172 irus-specific cell-mediated immunity in both simian immunodeficiency virus (SIV)-infected and uninfec

173 ts were detectable, but increased 20-fold in simian immunodeficiency virus (SIV)-infected animals.

174 ejuna, and livers of healthy and chronically simian immunodeficiency virus (SIV)-infected Asian macaq

175 iciency virus (HIV)-infected individuals and simian immunodeficiency virus (SIV)-infected Asian macaq

176 fected monocytes and macrophages to HIV- and simian immunodeficiency virus (SIV)-infected cells in vi

177 re loss of lean body mass and body weight in simian immunodeficiency virus (SIV)-infected juvenile rh

178 In simian immunodeficiency virus (SIV)-infected macaques, c

179 Antiretroviral-treated, chronically simian immunodeficiency virus (SIV)-infected rhesus maca

180 body-mediated CD8(+) lymphocyte depletion in simian immunodeficiency virus (SIV)-infected rhesus maca

181 s system (CNS) has not yet been reached, the simian immunodeficiency virus (SIV)-infected rhesus maca

182 A chronic ethanol feeding model in simian immunodeficiency virus (SIV)-infected rhesus maca

183 dictates the tempo of progression to AIDS in simian immunodeficiency virus (SIV)-infected rhesus maca

184 In a previous study, we found that in simian immunodeficiency virus (SIV)-infected rhesus maca

185 Simian immunodeficiency virus (SIV)-infected sooty manga

186 cells or purified CD4(+) T cells from HIV or simian immunodeficiency virus (SIV)-infected subjects wi

187 Using the simian immunodeficiency virus (SIV)-macaque model, we te

188 Here, we show a population of simian immunodeficiency virus (SIV)-specific CD8 T cells

189 Simian immunodeficiency virus (SIV)-specific CD8(+) T ce

190 Human immunodeficiency virus (HIV)- and simian immunodeficiency virus (SIV)-specific CD8(+) T ce

191 ian-human immunodeficiency virus (SHIV), and simian immunodeficiency virus (SIV).

192 on by human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV).

193 noculation (days postinoculation [dpi]) with simian immunodeficiency virus (SIV).

194 ol of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV).

195 erons, and impaired response to infection by simian immunodeficiency virus (SIV).

196 ains including clinical isolates, as well as simian immunodeficiency virus (SIV).

197 t they are not natural hosts of HIV-1 or any simian immunodeficiency virus (SIV).

198 tion of Env defines pathogenic properties of simian immunodeficiency virus (SIV).

199 ants in inducing protective immunity against simian immunodeficiency virus (SIV).

200 monkeys (AGMs) are natural primate hosts of simian immunodeficiency virus (SIV).

201 Chimeric simian immunodeficiency virus (SIV)/human immunodeficien

202 al, nasal, and vaginal vaccinations with DNA simian immunodeficiency virus (SIV)/interleukin-2 (IL-2)

203 Using the simian immunodeficiency virus (SIV)/rhesus monkey model

204 an green monkeys (AGMs) are natural hosts of simian immunodeficiency virus (SIVAGM).

205 e detected in the blood of Gambian primates: simian immunodeficiency virus (SIVagm; in 42% of animals

206 etherin, is associated with the evolution of simian immunodeficiency virus (SIVcpz) into pandemic gro

207 re targeted by primate lentiviruses (HIV and simian immunodeficiency virus [SIV]) are of intense inte

208 an immunodeficiency virus type 1 [HIV-1] and simian immunodeficiency virus [SIV]) if its activity is

209 d with non-MTB bacterial pathogens, nor with simian immunodeficiency virus alone.

210 nated monkeys to clear a subsequent virulent simian immunodeficiency virus challenge.

211 enhanced by substituting naturally occurring simian immunodeficiency virus Env residues at position 3

212 the result of cross-species transmission of simian immunodeficiency virus from chimpanzees (SIVcpz).

213 evant rhesus macaque model of infection with simian immunodeficiency virus from sooty mangabey (SIVsm

214 by electroporation (DNA/EP), all expressing Simian immunodeficiency virus group specific antigen/tra

215 the gut is well-maintained in nonpathogenic simian immunodeficiency virus infection as well as HIV-1

216 ontaining protein 1 (SAMHD1) restricts human/simian immunodeficiency virus infection in certain cell

217 tection from human immunodeficiency virus or simian immunodeficiency virus infection remain incomplet

218 Despite acute simian immunodeficiency virus infection, all animals rem

219 Here we show that in simian immunodeficiency virus infection, these cells are

220 agrees well with the experimental data from simian immunodeficiency virus infections in morphine-add

221 ng limiting-dose inoculations with a diverse simian immunodeficiency virus isolate stock may increase

222 of neutralization-resistant HIV-1, HIV-2 and simian immunodeficiency virus isolates, including a comp

223 ctious molecular clones from two widely used simian immunodeficiency virus lineages (SIVmac251 and SI

224 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus mac239 (SIV(mac239)) repli

225 and our current understanding comes from the simian immunodeficiency virus macaque model.

226 l reservoir during infections with HIV-1 and simian immunodeficiency virus of macaques (SIVmac).

227 degradation and inhibited wild-type SIVmac (simian immunodeficiency virus of macaques) infection of

228 iral protein X (Vpx) proteins from the major simian immunodeficiency virus of rhesus macaque, sooty m

229 Simian immunodeficiency virus SIVsab infection is comple

230 NK cell activity in cells infected with HIV, simian immunodeficiency virus, and other persistent viru

231 ue lungs by DeltasigH was not reactivated by simian immunodeficiency virus, despite high viral levels

232 s among uninfected animals exposed to HIV or simian immunodeficiency virus, irrespective of route of

233 However, simian immunodeficiency virus-induced reactivation of la

234 Notably, evaluation of simian immunodeficiency virus-infected nonhuman primates

235 We therefore used antifibrotic therapy in simian immunodeficiency virus-infected rhesus macaques t

236 uent mucosal challenge with a chimeric human/simian immunodeficiency virus.

237 , some of which may be linked to response to simian immunodeficiency virus.

238 emained at protective levels despite chronic simian immunodeficiency virus/HIV-induced immunosuppress

239 the differences between the Env proteins of simian immunodeficiency virus/simian HIV (SIV/SHIV) stoc

240 ugh nonhuman primate studies have shown that simian immunodeficiency virus/simian-human immunodeficie

241 Human and simian immunodeficiency viruses (HIV and SIV) exploit fo

242 ant for controlling replication of human and simian immunodeficiency viruses (HIV and SIV).

243 Lentiviruses such as HIV-2 and some simian immunodeficiency viruses (SIVs) counteract the re

244 ependent cross-species transmission event of simian immunodeficiency viruses (SIVs) infecting African

245 Simian immunodeficiency viruses (SIVs) use their Nef pro

246 er lentiviruses, including HIV-2 and related simian immunodeficiency viruses (SIVs), SAMHD1 restricti

247 en widely accepted to be the consequences of simian immunodeficiency viruses from wild chimpanzees (S

248 The Nef proteins of human and simian immunodeficiency viruses manipulate infected CD4(

249 h Nef is the viral gene product used by most simian immunodeficiency viruses to overcome restriction

250 Most simian immunodeficiency viruses use their Nef protein to

251 Inoculation of resulting simian liver chimeric mice with either HCV genotype 1a o

252 played an essential role in the evolution of simian neurotransmitter metabolism.

253 y virus (SIVagm; in 42% of animals), a novel simian pegivirus (SPgVagm; in 7% of animals), and numero

254 discovery and characterization of two novel simian pegiviruses (family Flaviviridae) and two novel s

255 overies demonstrate that in addition to SIV, simian pegiviruses and simian arteriviruses are widespre

256 The nonenveloped simian polyomavirus (PyV) simian virus 40 (SV40) hijacks

257 om HIV type 1 (HIV-1) and its vpu-containing simian precursors, may promote a selective preservation

258 o ventral premotor areas identified in other simian primates, and that area 8C corresponds to a speci

259 In simian primates, NK cell responses are regulated by inte

260 embrane protein called C18 in mobilizing the simian PyV SV40, a PyV archetype, from the ER into the c

261 Temperature-sensitive (ts) mutants of simian rotavirus (RV) strain SA11 have been previously c

262 in wild-type SA11 or a reassortant encoding simian RRV NSP1.

263 Previously, a mutant simian RV (SA11-tsC) that replicates worse at higher tem

264 correlate with restricted reassortment into simian RV strain SA11.

265 ted with the NSP1 gene and was observed in a simian SA11 monoreassortant that encoded porcine OSU NSP

266 icance of the B cell dysfunction observed in simian (SIV) and human immunodeficiency virus (HIV) infe

267 he immunodeficiency viruses, human (HIV) and simian (SIV); however, virus rebounds soon after ART is

268 Baboons naturally infected with simian T lymphotropic virus (STLV) are a potentially use

269 re we provide fundamental information on the simian T lymphotropic virus (STLV) naturally transmitted

270 ype D strain that was closely related to the simian T lymphotropic virus (STLV-1) that infects this m

271 Simian T-cell lymphotropic virus type 3 (STLV-3) is almo

272 he CD8(+) and CD4(+) T cell response against simian T-lymphotropic virus type 1 (STLV-1), a virus clo

273 e gene encoding a full-length protein in all simians under purifying selection and with similar shedd

274 t conferred partial cross-protection against simian varicella virus (SVV) challenge.

275 Simian varicella virus (SVV) infection of rhesus macaque

276 Since infection of rhesus macaques by simian varicella virus (SVV) is used as an animal model

277 Like varicella-zoster virus (VZV), simian varicella virus (SVV) reactivates to produce zost

278 ronchial inoculation of rhesus macaques with simian varicella virus (SVV) recapitulates the hallmarks

279 Infection of rhesus macaques with simian varicella virus (SVV), a homolog of VZV, provides

280 al inoculation of rhesus macaques (RMs) with simian varicella virus (SVV), a homolog of VZV, recapitu

281 nchially challenged with the closely related Simian Varicella Virus (SVV).

282 rn of PrP(res) accumulation in the body of a simian vCJD model.

283 eplicated efficiently and remained stable in simian Vero cells, which do not express these miRNAs, ho

284 ins for miRNA expression from rhesus macaque simian virus 40 (SV40) and human JC virus.

285 The nonenveloped simian polyomavirus (PyV) simian virus 40 (SV40) hijacks the endoplasmic reticulum

286 The nonenveloped simian virus 40 (SV40) hijacks the three endoplasmic ret

287 wever, the MWPyV LT was less stable than the simian virus 40 (SV40) LT and was unable to promote the

288 says, we have found that E7 can provide some simian virus 40 (SV40) or murine polyomavirus (PyV) ST f

289 M also suppressed the constitutively active simian virus 40 (SV40) promoter and globally decreased c

290 her defined oncogenic alleles, including the simian virus 40 (SV40) T antigen (TAg) and oncogenic H-R

291 re cultured in cell lines immortalized using simian virus 40 (SV40) T antigen, suggesting the possibi

292 defined oncogenic alleles, specifically the simian virus 40 (SV40) T antigens and oncogenic Ras(12V)

293 igenesis induced by transgenic expression of simian virus 40 (SV40) TAg in choroid plexus or intestin

294 The nonenveloped polyomavirus (PyV) simian virus 40 (SV40) traffics from the cell surface to

295 operties of nonhuman polyomaviruses, such as simian virus 40 (SV40), but is not required for MCV sT-i

296 -associated polyomaviruses (PyVs), including simian virus 40 (SV40), murine PyV, and Merkel cell PyV,

297 In the case of the nonenveloped polyomavirus simian virus 40 (SV40), the virus penetrates the endopla

298 a luciferase reporter vector containing the simian virus 40 promoter.

299 interactions of a whole nonenveloped virus (simian virus 40), as well as those of the hepatitis delt

300 llows it to be recognized by Vpx proteins of simian viruses infecting those primate species, which no